Continual Professional Development (CPD)
Keep up to date in this fast changing clinical area with accredited educational resources designed to test your knowledge and support the early diagnosis of cancer.
These resources have been developed or complied by Cancer Research UK in partnership with relevant clinical experts and organisations including Doctors.net.uk, RCGP, BMJ and the Department of Health. Most of the resources are open access, some are located on the other organisations' websites, and some might require a login.
Primary Care Cancer Toolkit
A collection of key evidence-based resources about cancer prevention, diagnosis and care relevant for the primary care setting from CRUK and RCGP. Open access to all health professions.
Behaviour Change and Cancer Prevention course
An 30 minute e-learning module providing the latest evidence, guidance and support on very brief advice specifically designed to implement in their practice in the UK, from CRUK and RCGP. Open access to all health professions free on RCGP registration for general access.
Screening for cervical cancer
How to advise women who are worried about cervical cancer, what information you should give them and how to advise women who have questions about the NHS cervical screening programme.
Oral cancer toolkit
NICE (2015) guideline summary
How and why the NICE guideline for suspected cancer referral has changed, the most important changes in referral criteria for adults, the important groups of patients who warrant direct access testing in primary care and when to refer a child for suspected cancer.
A module developed in association with Target Ovarian Cancer based on the NICE Clinical Guideline CG122 and is an opportunity to think in greater detail about presenting symptoms and consider which factors might distinguish ovarian cancer from common conditions.
Newsletters targeted at health professionals which provide intelligence to support evidence-based decision making, update on our activities and give practical guidance, useful tools and resources.